Rheumatology

Publications

Acharya, NR; Ramanan, AV; Coyne, AB; Dudum, KL; Rubio, EM; Woods, SM; Guly, CM; Moraitis, E; Petrushkin, HJ D; Armon, K; Puvanachandra, N; Choi, JT; Hawley, DP; Arnold, BF; ADJUST Study Group, . Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial. The Lancet. 2025; 405:303-313.

Arnaud, L; Ruiz-Irastorza, G; Aranow, C; Bernatsky, S; Dall'Era, M; Adelowo, O; Bae, SC; Beretta, L; Bonfa, E; Cervera, R; Svenungsson, E; Tamirou, F; Tegzová, D; Tektonidou, MG. ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations. The Lancet. Rheumatology. 2025; 7:e505-e518.

Baldo, F; Erkens, RG A; Mizuta, M; Rogani, G; Lucioni, F; Bracaglia, C; Foell, D; Gattorno, M; Jelusic, M; Anton, J; Ruperto, N; Swart, JF; Vastert, S; Minoia, F. Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project. Rheumatology. 2025; 64:32-44.

Barraclough, M; Mckie, S; Rittner, L; Knight, A; Katz, P; Hanly, J; Legge, A; Mackay, M; Dobrowolski, C; Brunner, H; Parker, B; Bruce, I; Touma, Z; Appenzeller, S. INTERNATIONAL EFFORT IN HARMONIZING COGNITIVE IMPAIRMENT RESEARCH IN SYSTEMIC LUPUS ERYTHEMATOSUS. The Journal of rheumatology. 2025; 52:39-40.

Basaran, O; Sag, E; Aydın, EA; Aydın, B; Tasdemir, NK; Celikel, E; Bayındır, Y; Özdel, S; Bilginer, Y; Grom, AA; Ozen, S. Lack of HLH in FMF. Pediatric Rheumatology Online Journal. 2025; 23:14.

Brandon, TG; Xiao, R; Lovell, DJ; Oberle, E; Stoll, ML; Chauvin, NA; Francavilla, ML; Maksymowych, WP; Weiss, PF. Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis. Arthritis Care and Research. 2025; 77:1229-1239.

Brunner, HI; Shmagel, A; Horneff, G; Foeldvari, I; Antón, J; Ramanan, AV; Qian, Y; Unnebrink, K; Hao, S; Camp, HS; Khan, N; Liu, W; Mohamed, ME F. Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open-Label, Phase 1 Trial. Arthritis Care and Research. 2025; 77:584-593.

Carol, HA; Mayer, AS; Zhang, MS; Dang, V; Varghese, J; Martinez, Z; Schneider, C; Baker, J; Tsoukas, P; Behrens, EM; Schulert, G; Lee, P; Kernan, KF; Canna, SW. Hyperferritinemia Screening to Aid Identification and Differentiation of Patients with Hyperinflammatory Disorders. Journal of Clinical Immunology. 2025; 45:4.

Case, S; Hill, CL; Shrader, P; Dennos, A; Phillips, T; Schanberg, LE; von Scheven, E; Barbour, K; Knight, AM; Hersh, A; Son, M; CARRA Registry Investigators, . Disease activity trajectories in paediatric lupus and associations with socioeconomic factors and patient-reported pain. Lupus Science and Medicine. 2025; 12:e001521.

Chiriboga, K; Zeller, M; LaPlante, M; Prasad, C. A survey of sexual harassment and assault in osteopathic medical schools. BMC Medical Education. 2025; 25:873.

Cody, EM; Sproles, A; Rose, J; Huang, B; Devarajan, P; Brunner, HI; Thornton, S. Development and Validation of Multiplex Assays for Lupus Nephritis Activity Biomarkers. Kidney International Reports. 2025; 10:2255-2264.

Connelly, K; Koelmeyer, R; Ayton, D; May, J; Gregory, K; Eades, LE; Barallon, R; Kandane-Rathnayake, R; Golder, V; Anzum, A; Furie, RA; van Vollenhoven, RF; Banerjee, S; Morand, E. Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study. Lupus Science and Medicine. 2025; 12:e001484.

Consolaro, A; Ruperto, N; Lovell, DJ; Synoverska, O; Abud-Mendoza, C; Spindler, A; Vyzhga, Y; Alexeeva, E; Chaitow, J; Chiraseveenuprapund, P; Lazariciu, I; Stockert, L; Cadatal, MJ; Diehl, A; Brunner, HI. Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial. The Journal of rheumatology. 2025; 52:919-926.

Cook, E; Schulert, G; Grom, A; Towe, C; Burg, G; Marsh, R; Chandra, S. Experience with T Cell–Depleted Allogeneic HSCT for Refractory sJIA Associated with Lung Disease. 2025; 1.

Correll, C; Burciu, A; Bansal, A; Dennos, A; Narayanswamy, D; Aubrun, E; Schanberg, LE; Yuhan, L; Schneider, R; Balevic, S; Sloan, E; Sivaraman, V; Singer, N; Shishov, M. Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. Pediatric Rheumatology Online Journal. 2025; 23:105.

Cunningham, NR; Danguecan, AN; Ely, SL; Amponsah, Y; Davis, A; Edison, S; Harris, J; Jones, JT; Goldstein-Leever, A; Manning, A; Treemarcki, E; Winner, K; Rubinstein, TB; Knight, AM. American College of Rheumatology Guidance Statements for Addressing Mental Health Concerns in Youth With Pediatric Rheumatologic Diseases. Arthritis Care and Research. 2025; 77:953-964.

De Lisa, R; de Andres-Trelles, F; Bax, R; Galluzzo, S; Alward, B; Thomson, A; Karres, D; Brunner, HI; Ruperto, N; Egger, GF. New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development. Frontiers in Medicine. 2025; 12:1583140.

DiFrancesco, M; Brunner, H. VOLUME AND DYNAMIC BLOOD FLOW OF THE CHOROID PLEXUS IN NEUROINFLAMMATORY DISEASE. The Journal of rheumatology. 2025; 52:106-107.

DiFrancesco, M; Wilson, E; Brunner, H. POS1400 PERIVENTRICULAR ABNORMALITY GRADIENTS OF RELAXOMETRY AND SUSCEPTIBILITY METRICS BY NEUROIMAGING: COMPARING LUPUS AND MULTIPLE SCLEROSIS. Annals of the Rheumatic Diseases. 2025; 84:1421-1422.

Eloseily, E; Pickering, A; Dhakal, S; Ruperto, N; Brunner, HI; Grom, AA; Thornton, S. Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction. Arthritis Care and Research. 2025; 77:513-521.

Esteban, Y; Avar-Aydin, PO; Ting, TV; Cassedy, A; Vega-Fernandez, P. Sonographic and Disease Activity Findings Related With Medication Change in JIA: A Historical Cohort Study. Journal of Clinical Rheumatology: practical reports on rheumatic and musculoskeletal disease. 2025; 31:20-25.

Foeldvari, I; Bohn, M; Petrushkin, H; Angeles Han, S; Bangsgaard, R; Calzada-Hernández, J; Constantin, T; de Boer, JH; Díaz-Cascajosa, J; Edelsten, C; Simonini, G; Solebo, AL; Titz, J; Anton, J. A practical approach to uveitis screening in children with juvenile idiopathic arthritis. British Journal of Ophthalmology. 2025; 109:372-376.

Foeldvari, I; Solebo, A; Petrushkin, H; Angeles-Han, ST; Bangsgaard, R; Calzada-Hernández, J; Constantin, T; de Boer, J; Díaz-Cascajosa, J; Glerup, M; Simonini, G; Swart, JF; Titz, J; Antón, J. Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood. Arthritis Care and Research. 2025; 77:1106-1111.

Hamdi, W; Migowa, A; Ferjani, HL; Makhloufi, CD; Makhlouf, Y; Nasef, SI; Ziade, N; Baraliakos, X; Brunner, H; Hassan, M; Furia, FF; Slimani, S; Scott, C; Hadef, D. Pediatric Society of the African League Against Rheumatism juvenile idiopathic arthritis recommendations for enthesitis-related arthritis and juvenile psoriatic arthritis. Clinical Rheumatology. 2025; 44:901-922.

Henderson, LA; Abraham, RS; Ahmed, A; Blount, L; Canna, SW; Chaimowitz, NS; Chandrakasan, S; Coates, B; Connelly, JA; Cooper, MA; Vogel, T; Walkovich, K; Zinter, MS; Behrens, EM. Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation. Frontiers in Immunology. 2025; 16:1519955.

Jones, OY; McCurdy, DK; Spencer, CH; Lovell, DJ. Juvenile Idiopathic Arthritis-The Rubik's Cube of Pediatric Rheumatology. Children. 2025; 12:1319.

Kasap-Cuceoglu, M; Huggins, J; Ting, T; Smith-Rodriguez, J; Merritt, A; Brunner, H. POS1172 EVALUATING THE STANDARDIZED STEROID REGIMEN (SSR) FOR CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: RETROSPECTIVE INSIGHTS FROM REAL-WORLD DATA. Annals of the Rheumatic Diseases. 2025; 84:1242-1243.

Kudira, R; Yang, ZF; Osuji, I; Damen, MS M A; Yang vom Hofe, A; Singh, M; Karns, R; Bariya, P; Pfuhler, L; Mullen, M; Subramanian, S; Salomonis, N; Miraldi, ER; Miethke, AG. Bile acids engage the SIPR-STAT3 signaling axis to modulate regulatory T cell responses in fibrosing cholangiopathies. Journal of Hepatology. 2025; 83:1128-1141.

Li, Y; Huang, B; Andorf, S; Yue, X; Lovell, DJ; Brunner, HI. Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease-Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta-Analysis of Randomized Controlled Trials. ACR Open Rheumatology. 2025; 7:e11788.

Macaraeg, M; Baker, E; Handorf, E; Matt, M; Brunner, H; Grom, AA; Henrickson, M; Huggins, J; Zhang, W; Lee, P; Marsh, R; Schulert, GS. Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers. Arthritis and Rheumatology. 2025; 77:596-605.

Macaraeg, M; Sood, A; Guner, ME; Guner, MK; Schulert, G; Mahajan, VB; Utz, VM; Angeles-Han, ST. Genetic Inflammatory Diseases with Ocular Involvement. Genetic Diseases of the Eye. : Oxford University Press (OUP); Oxford University Press (OUP); 2025.

Maccora, I; Altaye, M; Greis, KD; Brunner, HI; Duell, A; Haffey, WD; Nguyen, T; Quinlan-Waters, M; Schulert, GS; Sproles, A; Utz, VM; Thornton, S; Angeles-Han, ST. Candidate Tear-Based Uveitis Biomarkers in Children with JIA Based on Arthritis Activity and Topical Corticosteroid Use. Ocular Immunology and Inflammation (Informa). 2025; 33:603-612.

Maccora, I; Brunner, HI; Cassedy, A; Altaye, M; Quinlan-Waters, M; Lovell, DJ; Grom, A; Angeles-Han, ST. Achieving Medication-Free Remission in Patients With Juvenile Dermatomyositis. ACR Open Rheumatology. 2025; 7:e11751.

Mannion, ML; Aswani, MS; Hearld, KR; Smitherman, EA; Timmerman, L; Curtis, JR; Zic, C; Zhu, A; Zheng, Z; Zhao, YD; Soep, J; Smith, J; Smith, C; Sloan, E. Disease activity at two consecutive registry visits and subsequent medication escalation for patients with juvenile idiopathic arthritis in the CARRA registry. Pediatric Rheumatology Online Journal. 2025; 23:77.

Matt, MG; Drozdov, D; Bendstrup, E; Glerup, M; Hauge, EM; Masmas, T; Schneider, EC; Zeilhofer, UB; Abu-Arja, RF; Driest, KD; Chandra, S; Grom, A; Schulert, GS; Marsh, RA. Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study. The Lancet. Rheumatology. 2025; 7:e243-e251.

Nguyen, K; Yasin, S; Fall, N; Grom, AA; Brunner, HI; Towe, C; Schulert, GS. Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis. Pediatric Rheumatology Online Journal. 2025; 23:74.

Ogbu, EA; Brunner, HI; Imundo, L. Systemic lupus erythematosus in childhood and adolescence. Dubois Lupus Erythematosus and Related Syndromes. : Elsevier; Elsevier; 2025.

Ogbu, EA; Brunner, HI; Imundo, L. 41 Systemic lupus erythematosus in childhood and adolescence. Dubois' Lupus Erythematosus and Related Syndromes. : Elsevier; Elsevier; 2025.

Ogbu, EA; Sagcal-Gironella, AC P; Eberhard, BA; Huggins, JM; Klein-Gitelman, MS; Onel, K; Chen, C; Huang, B; Brunner, HI. Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale. ACR Open Rheumatology. 2025; 7:e11737.

Ohnishi, T; Wilkerson, J; Bayat, N; Farhadi, PN; Faiq, A; Dillon, CF; Schiffenbauer, A; Parks, CG; Brunner, HI; Goldberg, B; Miller, FW; Rider, LG. Infections preceding diagnosis associated with myositis phenotypes in a national patient registry. Clinical and Experimental Rheumatology. 2025; 43:1204-1212.

Oseni, LA; Tryfonos, A; Basta, C; Vastardi, MA; Hammerschlag, MR. Pediatric Residents Knowledge of Penicillin Allergy. Clinical Pediatrics. 2025; 64:200-204.

Pacella, J; Rodriguez-Smith, J; Kessler, H; Mantell, BS. Catastrophic antiphospholipid antibody syndrome associated with ischaemic cardiomyopathy. Cardiology in the Young. 2025; 34:2706-2708.

Parks, CG; Wilkerson, J; Rose, KM; Faiq, A; Farhadi, PN; Bayat, N; Schiffenbauer, A; Brunner, HI; Goldberg, B; Sandler, DP; Miller, FW; Rider, LG. Occupational and Hobby Exposures Associated With Myositis Phenotypes in a National Myositis Patient Registry. Arthritis Care and Research. 2025; 77:104-115.

Pence, LJ; Aundhia, MA; Alanni, J; Jackson, AK; Lovell, DJ; Soe, KC. Post-Streptococcal Myositis: Etiology of Myalgia and Severe Inflammation in a Child. Pediatrics. 2025; 156:e2025070952.

Pons Estel, GJ; Quintana, R; Nieto, R; Brunner, H; Scolnik, M; Funes Soaje, C; Alba, P; Saurit, V; García, MA; Berbotto, G; Zazzetti, F; Orillion, A; Sbarigia, U; Pons-Estel, B. POS0841 THE RENAL ACTIVITY INDEX FOR LUPUS IDENTIFIES AND PREDICTS COMPLETE RENAL REMISSION OR ABSENCE OF KIDNEY INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 2025; 84:985-986.

Randell, RL; Schanberg, LE; Beard, C; Phillips, T; Hornik, CP; Cohen-Wolkowiez, M; Balevic, SJ; Rubinstein, T; Vasquez, N; Wahezi, D; Fennell, J; Jiang, Y; Rodgers, L; Swaffar, C. Effect of an Electronic Pill Bottle on Hydroxychloroquine Adherence in Pediatric Lupus: Results of a Novel Direct-to-Family Pilot Trial. ACR Open Rheumatology. 2025; 7:e11780.

Ringold, S; Ong, MS; Tomlinson, G; Natter, MD; Schanberg, LE; Del Gaizo, V; Feldman, BM; Murphy, KL; Kimura, Y; Amir, R; Dagci, A; Dalrymple, A; Datyner, E; Davis, A. Three-Year Outcomes and Latent Class Trajectory Analysis of the Childhood Arthritis and Rheumatology Research Alliance Polyarticular JIA Consensus Treatment Plans Study. Arthritis and Rheumatology. 2025; 77:1433-1441.

Romankevych, I; Singer, N; Huggins, J; Marathe, K; Merritt, A; Chen, C; Stockert, L; Pelletier, K; Wang, X; Shi, H; Huang, B; Brunner, H. Pharmacokinetics, effectiveness, tolerability and effect on quality of life of open-label tofacitinib for the treatment of moderately active mucocutaneous manifestations of SLE: results of a 76-week phase II study. Lupus Science and Medicine. 2025; 12:e001689.

Rosenbaum, D; Meyers, AB; Vega-Fernandez, P; Hailu, SS; Yaya-Quezada, C; Nguyen, JC. Juvenile Idiopathic Arthritis and Spondylarthritis. Seminars in Musculoskeletal Radiology. 2025; 29:249-266.

Ruperto, N; Li, C; Chinniah, K; Uziel, Y; Synoverska, O; Sawhney, S; Calvo, I; Louw, I; Lu, M; Patel, PN; Koch, GG; Martini, A; Lovell, DJ; Brunner, H. OP0212 EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. Annals of the Rheumatic Diseases. 2025; 84:176-177.

Ruperto, N; Lovell, DJ; Synoverska, O; Abud-Mendoza, C; Spindler, A; Vyzhga, Y; Reyhan, I; Grebenkina, L; Tirosh, I; Imundo, L; Ebrahim, A; Klaus, P; Martini, A; Brunner, HI. Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial. ACR Open Rheumatology. 2025; 7:e70097.

Rypdal, V; Brunner, HI; Feldman, BM; Ruperto, N; Aggarwal, A; Angeles-Han, ST; Backström, M; Balay-Dustrude, E; Bracaglia, C; De Benedetti, F; Vojinovic, J; Weiss, PF; Gottlieb, B; Consolaro, A. Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force. Annals of the Rheumatic Diseases. 2025; 84:1425-1436.

Sadun, RE; Cooper, JC; Belot, A; Avcin, T; Aggarwal, A; Ainsworth, J; Akinsete, A; Ardoin, SP; Beresford, MW; Bortey, L; Woodside, A; Lewandowski, LB; Smith, EM; CARRA SLE Committee and PReS Lupus Working Party, . Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research. Annals of the Rheumatic Diseases. 2025; 84:158-168.

Sammaritano, LR; Askanase, A; Bermas, BL; Dall'Era, M; Duarte-García, A; Hiraki, LT; Rovin, BH; Son, MB F; Alvarado, A; Aranow, C; Turgunbaev, M; Williams, JN; Turner, AS; Mustafa, RA. 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis and Rheumatology. 2025; 77:1115-1135.

Sammaritano, LR; Askanase, A; Bermas, BL; Dall'Era, M; Duarte-García, A; Hiraki, LT; Rovin, BH; Son, MB F; Alvarado, A; Aranow, C; Turgunbaev, M; Williams, JN; Turner, AS; Mustafa, RA. 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis Care and Research. 2025; 77:1045-1065.

Sandborg, CI; Schulert, GS; Kimura, Y. Juvenile Idiopathic Arthritis. The New England Journal of Medicine. 2025; 393:162-174.

Schulert, GS. Update on new autoinflammatory disorders from the 2024 Pediatric Rheumatology European Society Congress. Pediatric Rheumatology Online Journal. 2025; 23:107.

Shalen, J; Austenfeld, E; Vater, M; Curran, M; Hayward, K; Mehta, J; Gillispie-Taylor, M; Argraves, M; Nguyen, J; Sadun, R; Steinberg, E; Stojkic, I; von Scheven, E; Wu, E. Essential Areas of Knowledge in Rheumatology for Pediatric Residents: A Modified Delphi Study. Pediatrics. 2025; 156:e2024069821.

Shishov, M; Weiss, PF; Levy, DM; Chang, JC; Angeles-Han, ST; Ogbu, EA; Nanda, K; Sherrard, TM; Goldmuntz, E; Lovell, DJ; Rider, LG; Brunner, HI. 25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges. Arthritis Care and Research. 2025; 77:573-583.

Soulsby, WD; Olveda, R; He, J; Berbert, L; Weller, E; Barbour, KE; Greenlund, KJ; Schanberg, LE; von Scheven, E; Hersh, A; Dean, J; DeCoste, C; Dedeoglu, F; DeGuzman, M. Racial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study. Arthritis Care and Research. 2025; 77:38-49.

Tursi, AR; Lages, CS; Quayle, K; Koenig, ZT; Loni, R; Eswar, S; Cobeña-Reyes, J; Thornton, S; Tilburgs, T; Andorf, S. Automated descriptive cell type naming in flow and mass cytometry with CytoPheno. Scientific Reports. 2025; 15:26750.

Utz, VM; Cassedy, A; Duell, A; Quinlan-Waters, M; Kaufman, AH; Angeles-Han, S. 116 Clinical characteristics and quality of life measures in children with glaucoma suspect or glaucoma diagnoses in chronic, non-infectious uveitis. Journal of American Association for Pediatric Ophthalmology and Strabismus. 2025; 29:104398.

Vega-Fernandez, P; Huggins, J; Angeles-Han, S; Lovell, DJ; Brunner, H; Rogers, K; Quinlan-Waters, M; Thornton, S; Cassedy, A; Ting, T. POS0295 RELATIONSHIP AMONG A PEDIATRIC-SPECIFIC ULTRASOUND SCORING SYSTEM FOR THE EVALUATION OF ARTHRITIS AND BIOLOGIC MARKERS OF INFLAMMATION. Annals of the Rheumatic Diseases. 2025; 84:556.

Wendroth, R; Paisley, A; Marsh, R; Schulert, G; Wikenheiser-Brokamp, KA; Burg, G. Lung Disease in Systemic Juvenile Idiopathic Arthritis: An Atypical Path to Diagnosis. American Journal of Respiratory and Critical Care Medicine. 2025; 211:a7865.

Wuller, S; Singer, NG; Lewis, C; Karlson, EW; Schulert, GS; Goldman, JD; Hadlock, J; Arnold, J; Hirabayashi, K; Stiles, LE; Deacy, M; Bissell, MM; Clark, M; Emmett, M. Severity of acute SARS-CoV-2 infection and risk of new-onset autoimmune disease: A RECOVER initiative study in nationwide U.S. cohorts. Editor, Yon DK. PloS one. 2025; 20:e0324513.

Yung, EM; Fridley, A; Matheny, T; Brunner, HI. Navigating the Biosimilars from Bench to Bedside in Juvenile Idiopathic Arthritis. Pediatric Drugs. 2025; 27:679-691.

Zhao, J; Zhao, X; Mizuno, T; Irie, K; Devarajan, P; Brunner, HI; Setchell, KD R. Volumetric Absorptive Microsampling Combined with Mass Spectrometry to Support Pharmacokinetically-Guided Precision Dosing of Mycophenolate Mofetil in Pediatric Lupus Nephritis Patients. The journal of applied laboratory medicine. 2025; 10:806-819.